Rx Item-Menactra Meningitis Vaccine 4Mcg 0.5Ml Vial 5X1 By Sanofi Pasteur

Clinical Information
Gen. Code and Des.
63830 mening vac A,C,Y,W-135 dip/PF INTRAMUSC VIAL 4MCG/0.5ML
GCN and Des.
99539 mening vac A,C,Y,W-135 dip/PF INTRAMUSC VIAL 4MCG/0.5ML
Strength
Dose Form
VIAL (ML)
Product Category
RX Pharmaceuticals
Fine Line Class
850085008510 All Rx Products
DEA Class
NC
OMP Family

AHFS Class
80120000 VACCINES
Active Ingredients
8836 meningococcal vaccine A,C,Y and W-135, dip tox con
9870 preservative free





MENACTRA- neisseria meningitidis group a capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group c capsular polysaccharide diphtheria toxoid conjugate antigen, neisseria meningitidis group y capsular polysaccharide diphtheria toxoid conjugate antigen and neisseria meningitidis group w-135 capsular polysaccharide diphtheria toxoid conjugate antigen injection, solution
Sanofi Pasteur Inc.

1 INDICATIONS AND USAGE

Menactra� , Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine, is indicated for active immunization to prevent invasive meningococcal disease caused by N meningitidis serogroups A, C, Y and W-135. Menactra vaccine is approved for use in individuals 9 months through 55 years of age. Menactra vaccine does not prevent N meningitidis serogroup B disease.

2 DOSAGE AND ADMINISTRATION

2.1 Preparation for Administration


Menactra vaccine is a clear to slightly turbid solution. Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. If any of these conditions exist, the vaccine should not be administered.

Withdraw the 0.5 mL dose of vaccine from the single-dose vial using a sterile needle and syringe.

2.2 Dose and Schedule
Menactra vaccine is administered as a 0.5 mL dose by intramuscular injection. Do not administer this product intravenously or subcutaneously.

? Primary Vaccination:

In children 9 through 23 months of age, Menactra vaccine is given as a 2-dose series three months apart.
Individuals 2 through 55 years of age, Menactra vaccine is given as a single dose.
? Booster Vaccination:

? A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease, if at least 4 years have elapsed since the prior dose.
3 DOSAGE FORMS AND STRENGTHS

Menactra vaccine is a solution supplied in 0.5 mL single-dose vials. [See Description (11) for a complete listing of ingredients.]

RX ITEM-Menactra 4Mcg 0.5Ml Vial 5X1 By
Item No.:RX946881/A, Item No. RX946881, 946881, NDC No.: 49281-0589-05, 49281-589-05, 4928158905, 49281058905, 0589-05, 058905 UPC No. 3-49281-58905-8, 349281-589058, 349281589058

Menactra 4Mcg 0.5Ml Vial 5X1 By Sanofi P
BRAND: MENACTRA NDC: 49281-0589-05,49281058905 UPC: 3-49281-58905-8,349281589058 Sanofi Pasteur

MENING VAC A,C,Y,W-135 DI
Only Lic.-Physician,Pharmacy,Dentist,Drug Mfg,Dist.,Gov,Hospital,Lic.Lab,Naturalist,Naturopath,NP,Optometrist,Pharmacist,PA,Physical Therapist,Podiatrist,Research Co.,Uni.,VA,Vet & Wholesalers in scop

Buy More Save More!
Want to do Research on this Med or need a large quantity? Email Details with quantity required to:[email protected]

AmericanPharmaWholesale.com
Visit AmericanPharmaWholesale.com for over 100,000 items of Health & Beauty at Retail@Wholesale prices.